What is the difference between Evie Ring (and EvieMED) and Whoop (5.0 / MG)?

Evie Ring (and EvieMED) and Whoop (5.0 / MG) are both biometric robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.

Is Evie Ring (and EvieMED) or Whoop (5.0 / MG) more autonomous?

Whoop (5.0 / MG) has more capabilities independently verified as autonomous on the DEPLOY registry than Evie Ring (and EvieMED). DEPLOY counts a capability as autonomous only when verified at a real deployment, not from a demo or a vendor claim.

Which has more verified deployments, Evie Ring (and EvieMED) or Whoop (5.0 / MG)?

Evie Ring (and EvieMED) and Whoop (5.0 / MG) each have 1 verified deployment on the DEPLOY registry (confirmed at named sites with primary sources).

Buying guide

Evie Ring (and EvieMED) vs Whoop (5.0 / MG) in 2026

Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.

Key differences

Whoop (5.0 / MG) has more capabilities independently verified as autonomous (2 vs 0).

Attribute	No image on file Evie Ring (and EvieMED)View full model page →	Whoop (5.0 / MG)View full model page →
Manufacturer	Movano Health	Whoop
Form factor	biometric	biometric
Maturity	commercial	commercial
Autonomy	—	✓ 2 verified autonomous
Availability	pausedpaused	shipping-nowshipping
Price	Not announced	$199-$359/year lease (actual sale price)
Capability claims	—	Tracks sleep (autonomous, verified) Tracks stress and recovery (autonomous, verified) Tracks heart health (claimed-only, claimed) Tracks body temperature (claimed-only, claimed)
Brain	—	—
Verified deployments	1United States	1Global
Privacy practices	—	13data-retention, third-party-sharing, data-sale, third-party-sharing, biometric-storage, training-data-use, data-deletion-control, third-party-sharing, location-tracking, data-sale, data-deletion-control, data-retention, biometric-storage
Sources on file	8	22

Editorial summaries

Evie Ring (and EvieMED)

Movano Health's Evie Ring is a women's-health-focused smart ring (menstrual-cycle tracking, sleep, energy, heart rate, SpO2, and mood and goal trends; general-wellness, not a diagnostic) and the lifecycle-state-paused archetype of DEPLOY's biometric ring sub-cohort. The verified-vs-claimed distinction is critical: Evie Ring sales are PAUSED, not discontinued. Following Movano Health's Corvex reverse merger (closed March 19, 2026), an AI-infrastructure pivot, and a 1-for-10 reverse split, the company paused Evie Ring sales while a divestiture of its EvieMED clinical line is pending. EvieMED (the B2B/clinical variant) is an FDA 510(k)-cleared pulse oximeter and heart-rate device (December 2, 2024) for clinical trials, remote patient monitoring, and payors and pharma. DEPLOY records the consumer Evie Ring at paused availability with no current retail price. Aggregators routinely flatten this as 'Movano discontinued the Evie Ring'; the accurate state is sales-paused amid a corporate pivot, with the EvieMED divestiture pending (an intention where not yet closed). Movano Health trades as NASDAQ: MOVE (CEO John Mastrototaro).

Whoop (5.0 / MG)

Whoop (the 5.0 and the 'Medical Grade' MG, both launched May 8, 2025, from Whoop, founded 2012 in Boston by Will Ahmed) is a screen-free biometric wrist band and the subscription-only archetype of the biometric cohort: there is no standalone hardware sale. Access is a membership, Whoop One at $199/year, Peak at $239/year, and Life at $359/year (which includes the MG hardware), with the band provided inside the subscription. Its PPG, skin-temperature, SpO2, and respiratory sensors feed Strain, Recovery, and Sleep Coach analytics and an LLM 'Whoop Coach'; the MG adds ECG, Blood Pressure Insights, and a Healthspan / 'Whoop Age' feature. DEPLOY records commercial maturity and a reported $10.1 billion valuation (March 2026). Whoop is the strongest verified-vs-claimed cautionary exemplar in the cohort: its ECG is FDA-cleared (2025), but it marketed Blood Pressure Insights without clearance, drew an FDA Warning Letter on July 14, 2025, refused to remove the feature, and as of May 2026 the matter is unresolved with a class action filed, the market-first contrast to Oura's study-first posture.

Common questions

What is the difference between Evie Ring (and EvieMED) and Whoop (5.0 / MG)?: Evie Ring (and EvieMED) and Whoop (5.0 / MG) are both biometric robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.
Is Evie Ring (and EvieMED) or Whoop (5.0 / MG) more autonomous?: Whoop (5.0 / MG) has more capabilities independently verified as autonomous on the DEPLOY registry than Evie Ring (and EvieMED). DEPLOY counts a capability as autonomous only when verified at a real deployment, not from a demo or a vendor claim.
Which has more verified deployments, Evie Ring (and EvieMED) or Whoop (5.0 / MG)?: Evie Ring (and EvieMED) and Whoop (5.0 / MG) each have 1 verified deployment on the DEPLOY registry (confirmed at named sites with primary sources).

Recent coverage

Whoop Promo Codes: 20% Off This July 2026Whoop (5.0 / MG) · Wired · 2026-07-02
Movano Health secures FDA clearance for EvieMED RingEvie Ring (and EvieMED) · AgentRecon · 2026-06-15
FDA exempts more wearable AI features from oversightEvie Ring (and EvieMED) · AgentRecon · 2026-04-15

Related comparisons

For AI assistants

Use DEPLOY in Claude, Cursor, and other AI assistants

Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.

Install instructions Download for Claude Desktop

Machine-readable: this page as markdown.

← Back to all consumer robots